×


 x 

Shopping cart
11%OFFAlexander Schuhmacher - Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation - 9783527339136 - V9783527339136
Stock image for illustration purposes only - book cover, edition or condition may vary.

Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation

€ 107.61
€ 95.78
You save € 11.83!
FREE Delivery in Ireland
Description for Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation Hardback. Written by a team of editors and authors with extensive experience in the industry and at some of Europe's most prestigious business schools this is a practical, must-have guide for young professionals and MBA students preparing to enter R&D in pharma and biotech. Num Pages: 552 pages. BIC Classification: KJ; PN; PS. Category: (P) Professional & Vocational. Dimension: 244 x 170. .
This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation.
A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments ... Read more

Product Details

Publisher
Wiley-VCH Verlag GmbH Germany
Number of pages
552
Format
Hardback
Publication date
2016
Condition
New
Weight
1226g
Number of Pages
508
Place of Publication
Berlin, Germany
ISBN
9783527339136
SKU
V9783527339136
Shipping Time
Usually ships in 4 to 8 working days
Ref
99-1

About Alexander Schuhmacher
Prof. Dr. Alexander Schuhmacher is a professor for R&D management, Vice Dean of the Faculty of Applied Chemistry and Senator at Reutlingen University. And he is Director for R&D performance metrics and business model innovation at Bioscience Valuation. Before joining the academic world, he worked 14 years in the pharmaceutical industry in various functions in R&D, such as in R&D ... Read more

Reviews for Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation

Goodreads reviews for Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation


Subscribe to our newsletter

News on special offers, signed editions & more!